In the current month, DCOY has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. DCOY average Analyst price target in the last month is 3.000.
Based on analysts' estimates, DCOY EPS is projected to reach -1.110 in FY2026Q4, following reported EPS of -3.534 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -3.53, while Salarius Pharmaceuticals Ord ShsDCOY's earnings per share (EPS) for the previous quarter was USD -4.46. EPS for the next quarter is expected at USD -2.16.